Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions?
Ann Rheum Dis
.
2019 Jun;78(6):e46.
doi: 10.1136/annrheumdis-2018-213440.
Epub 2018 Apr 17.
Authors
Pier Luigi Meroni
1
,
Edward K Chan
2
,
Jan Damoiseaux
3
,
Luís Eduardo Coelho Andrade
4
,
Xavier Bossuyt
5
,
Karsten Conrad
6
,
Xavier Mariette
7
,
Joanna Sheldon
8
,
Johan Rönnelid
9
,
Marvin J Fritzler
10
;
members of the committees
Affiliations
1
Immunorheumatology Research Laboratory, IRCCS Istituto Auxologico Italiano, Milan, Italy.
2
Department of Oral Biology, University of Florida, Gainesville, Florida, USA.
3
Laboratory Specialist Medical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands.
4
Departamento de Reumatologia, Fleury Laboratory, Immunology, Universidade Federal de São Paulo, Sao Paulo, Brazil.
5
Department of Laboratory Medicine, University Hospital Leuven, Leuven, Belgium.
6
Institut für Immunologie Medizinische, Carl Gustav Carus" der Technischen Universität Dresden, Dresden, Germany.
7
Department of Rheumatology, Université Paris-Sud, Paris, France.
8
Center for Infection and Immunity Research, St George's, University of London, London, UK.
9
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
10
Department of Medicine and Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada.
PMID:
29666046
DOI:
10.1136/annrheumdis-2018-213440
No abstract available
Keywords:
autoimmune diseases; disease activity; treatment.
Publication types
Letter
Comment
MeSH terms
Antibodies, Antinuclear*
Autoimmune Diseases*
Biological Assay
Fluorescent Antibody Technique, Indirect
Humans
Substances
Antibodies, Antinuclear